secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2021-08-27T23:59:59+00:00
Accession:  0001193125-21-257910
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.95
Item codes: 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 9.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerpio completes reverse merger with Aadi, changes name to Aadi Bioscience, raises $155M PIPE
--------------------------------------------------------------------------------

- Former Aadi stockholders received ~0.3172 shares per Aadi share; post-merger ownership: Aadi 29.2%, former Aerpio 15.2%, PIPE 55.6%.
- PIPE financing of $155M from 11.85M shares at ~$13.08/sh; Avoro Capital (affiliated with new director) invested $25M for ~1.91M shares.
- New board of 7 directors: Caley Castelein (Chair), Neil Desai, Anupam Dalal, Karin Hehenberger, Behzad Aghazadeh, Richard Maroun; one vacancy.
- Reverse stock split 15:1, name change to Aadi Bioscience, ticker symbol changes to AADI on Nasdaq effective Aug 27, 2021.
- Contingent value rights (CVRs) issued to former Aerpio stockholders; each CVR entitles holder to 90% of net proceeds from certain milestone payments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312521257910/0001193125-21-257910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312521257910/d119681d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-257910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer